. 2015 May 26;25(9):1003–1024. doi: 10.1517/13543776.2015.1050791
© Informa UK, Ltd.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
Figure 24.
General chemical structure of chloroquine derivatives for treatment of neuropathy.